Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24279280 | 0.89 | MEN1 (0.35) | ALDH1A1MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL14287347 | 0.85 | MEN1 (0.35) | ALDH1A1MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL20463326 | 0.85 | MEN1 (0.35) | ALDH1A1MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL19147849 | 0.83 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL21947606 | 0.81 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL24063006 | 0.80 | ALDH1A1 (0.33) | ALDH1A1MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL21549748 | 0.79 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL21126662 | 0.79 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL18427379 | 0.79 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL20953700 | 0.79 | ALDH1A1 (0.31) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210388196-A1 | GENE DELIVERY CARRIER | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-12-16 | — | — | US | disclosed |
| US-20190194390-A1 | AMINO-POLYESTERS FOR DRUG DELIVERY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210388196-A1 | GENE DELIVERY CARRIER | PAICS, PBDC1, BCAT1 | ALDH1A1 2765/4885MEN1 3571/4885CYP3A4 4399/4885 |
| US-20190194390-A1 | AMINO-POLYESTERS FOR DRUG DELIVERY | DNPEP, NPEPPS, ANPEP | ALDH1A1 1113/4885MEN1 4025/4885CYP3A4 2242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.